Displaying all 3 publications

Abstract:
Sort:
  1. Arman Alim AA, Baharum A, Mohammad Shirajuddin SS, Anuar FH
    Polymers (Basel), 2023 Jan 04;15(2).
    PMID: 36679142 DOI: 10.3390/polym15020261
    It is of significant concern that the buildup of non-biodegradable plastic waste in the environment may result in long-term issues with the environment, the economy and waste management. In this study, low-density polyethylene (LDPE) was compounded with different contents of poly(butylene succinate) (PBS) at 10-50 wt.%, to evaluate the potential of replacing commercial plastics with a biodegradable renewable polymer, PBS for packaging applications. The morphological, mechanical and thermal properties of the LDPE/PBS blends were examined in relation to the effect of polyethylene-graft-maleic anhydride (PE-g-MA) as a compatibilizer. LDPE/PBS/PE-g-MA blends were fabricated via the melt blending method using an internal mixer and then were compression molded into test samples. The presence of LDPE, PBS and PE-g-MA individually in the matrix for each blend presented physical interaction between the constituents, as shown by Fourier-transform infrared spectroscopy (FTIR). The morphology of LDPE/PBS/PE-g-MA blends showed improved compatibility and homogeneity between the LDPE matrix and PBS phase. Compatibilized LDPE/PBS blends showed an improvement in the tensile strength, with 5 phr of compatibilizer providing the optimal content. The thermal stability of LDPE/PBS blends decreased with higher PBS content and the thermal stability of compatibilized blends was higher in contrast to the uncompatibilized blends. Therefore, our research demonstrated that the partial substitution of LDPE with a biodegradable PBS and the incorporation of the PE-g-MA compatibilizer could develop an innovative blend with improved structural, mechanical and thermal properties.
  2. Saidi LK, Md Rani ZZ, Sulaiman SA, Jamal R, Ismail A, Alim AA, et al.
    Malays J Med Sci, 2024 Jun;31(3):92-106.
    PMID: 38984253 DOI: 10.21315/mjms2024.31.3.6
    BACKGROUND: The techniques for detecting single nucleotide polymorphisms (SNP) require lengthy and complex experimental procedures and expensive instruments that may only be available in some laboratories. Thus, a deoxyribonucleic acid (DNA)-based lateral flow assay (LFA) was developed as a point-of-care test (POCT) diagnostic tool for genotyping. In this study, single nucleotide variation (E101K) in the low-density lipoprotein receptor (LDLR) gene leading to familial hypercholesterolemia (FH) was chosen as a model.

    METHODS: Hypercholesterolemic individuals (n = 103) were selected from the Malaysian Cohort project (UKM Medical Molecular Biology Institute) while the control samples were selected from the Biobank (UKM Medical Molecular Biology Institute). The DNA samples were isolated from whole blood. Polymerase chain reaction (PCR) amplification process was performed using bifunctional labelled primers specifically designed to correspond to the variant that differentiates wild-type and mutant DNA for visual detection on LFA. The variant was confirmed using Sanger sequencing, and the sensitivity and specificity of the LFA detection method were validated using the Agena MassARRAY® technique.

    RESULTS: Out of 103 hypercholesterolemic individuals, 5 individuals (4.8%) tested positive for E101K, LDLR mutation and the rest, including healthy control individuals, tested negative. This result was concordant with Sanger sequencing and Agena MassARRAY®. These five individuals could be classified as Definite FH, as the DNA diagnosis was confirmed. The sensitivity and specificity of the variant detection by LFA is 100% compared to results using the genotyping method using Agena MassARRAY®.

    CONCLUSION: The developed LFA can potentially be used in the POC setting for detecting the E101K variant in the LDLR gene. This LFA can also be used to screen family members with E101K variant in the LDLR gene and is applicable for other SNP's detection.

  3. Nadzirah S, Mohamad Zin N, Khalid A, Abu Bakar NF, Kamarudin SS, Zulfakar SS, et al.
    Crit Rev Anal Chem, 2023 Jun 26.
    PMID: 37358486 DOI: 10.1080/10408347.2023.2224433
    Since diagnostic laboratories handle large COVID-19 samples, researchers have established laboratory-based assays and developed biosensor prototypes. Both share the same purpose; to ascertain the occurrence of air and surface contaminations by the SARS-CoV-2 virus. However, the biosensors further utilize internet-of-things (IoT) technology to monitor COVID-19 virus contamination, specifically in the diagnostic laboratory setting. The IoT-capable biosensors have great potential to monitor for possible virus contamination. Numerous studies have been done on COVID-19 virus air and surface contamination in the hospital setting. Through reviews, there are abundant reports on the viral transmission of SARS-CoV-2 through droplet infections, person-to-person close contact and fecal-oral transmission. However, studies on environmental conditions need to be better reported. Therefore, this review covers the detection of SARS-CoV-2 in airborne and wastewater samples using biosensors with comprehensive studies in methods and techniques of sampling and sensing (2020 until 2023). Furthermore, the review exposes sensing cases in public health settings. Then, the integration of data management together with biosensors is well explained. Last, the review ended with challenges to having a practical COVID-19 biosensor applied for environmental surveillance samples.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links